Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth

First Page		Document Content
Date: 2016-05-24 18:07:21 Transfusion medicine Apheresis LDL apheresis Erythrocytapheresis Hematopoietic stem cell transplantation Plateletpheresis Plasmapheresis Thrombotic thrombocytopenic purpura Levels of evidence Extracorporeal Cholesterol Platelet		Journal of Clinical Apheresis 28:145–Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Add to Reading List Source URL: inbcsaves.org Download Document from Source Website File Size: 4,01 MB Share Document on Facebook

	Sickle cell disease and hyperhemolysis: epidemiology, risk factors and new therapeutic approaches in France WORLD APHERESIS ASSOCIATION AND FRENCH SOCIETY FOR HEMAPHERESIS April 27-29, 2016, PARIS-FRANCE DocID: 1sjCl - View Document
	Who can make an apheresis donation? To qualify, donors must meet all required blood donation standards, including: • Be at least 17 years old. Donors under the age Making an apheresis donation is DocID: 1rrmk - View Document
	S7 KHOEL Manual exchanges WAA DocID: 1rnBM - View Document
	HemaT symposium Rheopheresis and distal arteriopathy [Mode de compatibilité] DocID: 1rnak - View Document
	Prediction Algorithms for Cell Therapy Collections, J. Roig WAA 2016 DocID: 1rhi1 - View Document